LWAC
SPHS

Laurel Wealth Advisors (California)’s Sophiris Bio, Inc. SPHS Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$21K – 388
2017
Q3 		$21K Hold
10,000
– – 0.01% 326
2017
Q2 		$22K Hold
10,000
– – 0.01% 309
2017
Q1 		$28K Hold
10,000
– – 0.01% 282
2016
Q4 		$28K Buy
+10,000
New +$28.3K 0.01% 261
2016
Q1 		– Sell
-84,600
Closed -$151K – 375
2015
Q4 		$151K Buy
+84,600
New +$125K 0.08% 239

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Laurel Wealth Advisors (California)'s SPHS Position: Q4 2017 in Review

Laurel Wealth Advisors (California) sold out of Sophiris Bio, Inc. (SPHS) in Q4 2017, closing a stake of 10,000 shares — an estimated $21K sold.

Laurel Wealth Advisors (California) first reported a position in SPHS in Q4 2015 and held it in 5 quarters. The position peaked at $151K in Q4 2015. 32 funds tracked by Wall St. Rank hold SPHS as of Q4 2017.

  • Laurel Wealth Advisors (California) reported no remaining Sophiris Bio, Inc. position as of Q4 2017 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 10,000 Sophiris Bio, Inc. shares in Q4 2017, an estimated $21K.
  • Laurel Wealth Advisors (California) first reported a position in Sophiris Bio, Inc. in Q4 2015 and held it in 5 quarters.
  • Laurel Wealth Advisors (California)'s Sophiris Bio, Inc. position peaked at $151K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2017.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2017, filed 15 Feb 2018.